Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease? [2]

Movement Disorders

Volumn 20, Issue 5, 2005, Pages 641-642

  Papapetropoulos, Spiridon ^a   Singer, Carlos ^a   Villar, Jose M ^a   Mash, Deborah C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; AUTOPSY; CIGARETTE SMOKING; COGNITIVE DEFECT; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RESEARCH; MOLECULAR MECHANICS; MOOD DISORDER; MORTALITY; NEUROPROTECTION; OUTCOMES RESEARCH; PARKINSON DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE SIZE; SMOKING CESSATION; SMOKING HABIT;

AGE OF ONSET; AGED; FEMALE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 20844455774     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20433     Document Type: Letter

References (3)

1. Alves G, Kurz M, Lie SA, Larsen JP. Cigarette smoking in Parkinson's disease: influence on disease progression. Mov Disord 2004; 19:1087-1092.
2. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
3. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.